At the recent American Heart Association meeting in Chicago, there was a growing consensus that surgery could provide a more permanent and sustainable solution to atrial fibrillation than life-long medical therapy. A number of practitioners at the meeting argued that medical therapy may have been given undue precedence based on shaky data, flawed analysis, and poor experience of new techniques.
A new study has highlighted the benefit of routine antibody testing in suspected cases of celiac disease. While these data prove the merit of serological testing, awareness of the disease remains a significant issue. Indeed, with almost no treatment options available, the development of an effective pharmacological therapy offers the potential to reap significant returns from this untapped market.
Edit my basket
© Datamonitor 2012. All rights reserved
Terms & Conditions